论文部分内容阅读
目的评价3种治疗冠心病心绞痛方案的疗效和经济学效果。方法筛选111例患者随机分为A、B、C组,分别用注射用灯盏花素50mg、丹红注射液20ml、丹参川芎嗪注射液10ml进行治疗,观察其临床疗效并进行成本-效果分析。结果A、B、C组总有效率分别为:84.61%、83.78%、85.71%;成本分别是824.60元、1108.52元、1214.36元;成本-效果比分别为9.75、14.49、12.93;B、C组相对于A组增量成本-效果比分别为469.59、258.11。结论注射用灯盏花素治疗组疗效好且更为经济。
Objective To evaluate the curative effect and economic effect of three kinds of treatment of coronary heart disease angina pectoris program. Methods 111 patients were randomly divided into A, B and C groups. Breviscapine (50mg), Danhong injection (20ml) and ligustrazine injection (10ml) were used respectively to observe the clinical effect and cost-effectiveness analysis. Results The total effective rates in groups A, B and C were 84.61%, 83.78% and 85.71% respectively; the costs were 824.60 yuan, 1108.52 yuan and 1214.36 yuan respectively; the cost-effectiveness ratios were 9.75, 14.49 and 12.93 respectively; Compared with the A group, the incremental cost-effectiveness ratios are respectively 469.59 and 258.11. Conclusion Breviscapine injection group is effective and more economical.